News

Through cost-saving practices for coffee, rice, corn and livestock production, Vietnam can take steps to meet Paris Agreement commitments and save the country an estimated $2.3 billion by 2030.

A synthetic, non-intoxicating analogue of cannabidiol (CBD) has been shown to be effective at treating seizures in rats, according to research by chemists at the University of California, Davis.

Nearly all humans silently harbor polyomavirus, a tiny DNA virus, but when transplant recipients receive drugs to suppress their immune system to prevent graft rejection, the virus can reactivate and damage the kidney. A new approach to targeting infected cells may help reduce viral load in transplant patients.

Results from three long-term studies following host and microbiome characteristics during pregnancy and preterm birth, inflammatory bowel disease, and prediabetes have expanded our understanding of how humans and microbes interact and the resulting consequences for our health.

Researchers have found a safer treatment for a specific type of leukemia. By refining a therapeutic avenue that was previously abandoned because of its severe side effects, they came up with a targeted approach that was both effective and safe in mice and in human cancer cells.

A new study finds that prehistoric humans "recycled" discarded or broken flint tools 400,000 years ago to create small, sharp utensils with specific functions.

Children with an inherited form of intellectual disability and autism could be helped by a medicine commonly used to lower cholesterol, if used early in life. The drug - called lovastatin - corrected learning and memory problems in rats with a form of Fragile X Syndrome, tests revealed.

Using artificial intelligence, researchers have succeeded in making the mass analysis of proteins from any organism significantly faster than before and almost error-free.

A metabolite of an alkaloid from kratom, a Southeast Asian tree with a long history of use in traditional medicine, could be responsible for the treatment’s therapeutic effects.

"DELFI", a new approach to cancer diagnostics, has shown promise in a proof-of-concept study. The test is based on machine learning and simultaneously analyzes millions of sequences to inspecting differences in cell-free DNA that are indicative of cancer.